ERYTECH and Catalent enter long-term supply agreement for eryaspase

ERYTECH and Catalent have entered a long-term supply agreement for the clinical and commercial supply of eryaspase (GRASPA).

“ERYTECH and Catalent to enter into a long-term supply agreement for clinical and commercial supply of eryaspase (GRASPA).”stocktitan.net

• 1 source
• stocktitan.netERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent | ERPY Stock NewsStock TitanApr 25, 2022

Summarized from public sources; check the original articles before acting on it.